About Pi-Cardia
Pi-Cardia is a company based in Rehovot (Israel) founded in 2009 by Erez Golan and Eyal Kolka.. Pi-Cardia has raised $40 million across 3 funding rounds from investors including Clal Biotechnology Industries, Jacques Séguin and Sofinnova Partners. Pi-Cardia offers products and services including ShortCut Device and Leaflex Performer. Pi-Cardia operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Peijia Medical Technologies and MicroPort CardioFlow Medtech Corporation, among others.
- Headquarter Rehovot, Israel
- Founders Erez Golan, Eyal Kolka
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$40 M (USD)
in 3 rounds
-
Latest Funding Round
$27 M (USD), Series D
Apr 20, 2020
-
Investors
Clal Biotechnology Industries
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pi-Cardia
Pi-Cardia offers a comprehensive portfolio of products and services, including ShortCut Device and Leaflex Performer. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tool for splitting bioprosthetic valve leaflets to prevent obstruction.
Device for next-generation aortic repair in heart disease.
Unlock access to complete
Funding Insights of Pi-Cardia
Pi-Cardia has successfully raised a total of $40M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $27 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series D — $27.0M
-
First Round
First Round
(10 Jan 2016)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Series D - Pi-Cardia | Valuation | Sofinnova Partners | |
| Dec, 2018 | Amount | Series C - Pi-Cardia | Valuation | Clal Biotechnology Industries |
|
| Jan, 2016 | Amount | Series C - Pi-Cardia | Valuation | Innogest Capital , VI Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pi-Cardia
Pi-Cardia has secured backing from 5 investors, including angel and venture fund investors. Prominent investors backing the company include Clal Biotechnology Industries, Jacques Séguin and Sofinnova Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in Israel and the US
|
Founded Year | Domain | Location | |
|
VC firm investing in seed and early stage companies in Italy
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pi-Cardia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pi-Cardia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pi-Cardia Comparisons
Competitors of Pi-Cardia
Pi-Cardia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Peijia Medical Technologies and MicroPort CardioFlow Medtech Corporation, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| domain | founded_year | HQ Location |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
|
| domain | founded_year | HQ Location |
Smart medical devices for heart valve diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pi-Cardia
Frequently Asked Questions about Pi-Cardia
When was Pi-Cardia founded?
Pi-Cardia was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Where is Pi-Cardia located?
Pi-Cardia is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Who is the current CEO of Pi-Cardia?
Erez Golan is the current CEO of Pi-Cardia. They have also founded this company.
Is Pi-Cardia a funded company?
Pi-Cardia is a funded company, having raised a total of $40M across 3 funding rounds to date. The company's 1st funding round was a Series C of $10M, raised on Jan 10, 2016.
What does Pi-Cardia do?
Pi-Cardia was established in 2009 in Rehovot, Israel, within the medical device sector focused on cardiology. Non-implant solutions for valve repair are produced, including the Leaflex device. Separation between calcium deposits on valve leaflets is created by its scoring lines, which restores leaflet flexibility, supports mobility, and enhances overall valve hemodynamics. Operations center on advancing treatments for structural heart conditions.
Who are the top competitors of Pi-Cardia?
Pi-Cardia's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
What products or services does Pi-Cardia offer?
Pi-Cardia offers ShortCut Device and Leaflex Performer.
Who are Pi-Cardia's investors?
Pi-Cardia has 5 investors. Key investors include Clal Biotechnology Industries, Jacques Séguin, Sofinnova Partners, Innogest Capital, and VI Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.